Cargando…
Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework
Autores principales: | Couillard, Simon, Pavord, Ian D., Heaney, Liam G., Petousi, Nayia, Hinks, Timothy S. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541235/ https://www.ncbi.nlm.nih.gov/pubmed/35591794 http://dx.doi.org/10.1111/resp.14294 |
Ejemplares similares
-
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
por: Couillard, Simon, et al.
Publicado: (2022) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
The Role of FeNO in Predicting Asthma
por: Pijnenburg, Mariëlle W.
Publicado: (2019) -
FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management
por: Verini, Marcello, et al.
Publicado: (2010) -
Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation
por: Riise, Gerdt C., et al.
Publicado: (2011)